Health Condition 1: K819- Cholecystitis, unspecified
Conditions
Interventions
Control Intervention1: ropivacaine 0.2 % plus magnesium 1 gram: intraperitoneally 40 ml
after removal of gall bladder and 10 ml for port site instillation once
Control Intervention2: ropivacaine 0.2%
Sponsors
DNB Resident Dissertation No financial support
Dr MC Rajesh Senior Consultant Anasthesiologist
Eligibility
Inclusion criteria
Inclusion criteria: PATIENTS WHO ARE ASA CLASS 1 OR 2 UNDERGOING ELECTIVE LAPROSCOPIC SURGERY BMI -18 TO 30
Exclusion criteria
Exclusion criteria: PATIENT WITH ECG SHOWING CONDUCTION ABNORMALITIES PREGNANT AND BREASTFEEDING PATIENT ON BETA BLOCKERS PATIENT WITH CHRONIC PAIN ON OPIOIDS AND OTHER ANALGESICS HISTORY OF ALLERGY TO STUDY DRUGS SURGERY DURATIONS MORE THAN THREE HOURS CONVERSION TO OPEN PROCEDURE EMERGENCY CHOLYCYSTECTOMY PATIENTS REQUIRING COMMON BILE DUCT EXPLORATION
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the 1.duration of analgesia after intraperitoneal instillation of ropivacaine with and without magnesium sulphate, 2.Mean pain scores during 24 hour , 3.total doses of rescue analgesics in each groups 4.type of pain.Timepoint: baseline,1 hour,2hour.6 hour,12 hour,24 hour | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary objective To study the post instillation hemodynamic changes in terms of heart rate(HR), systolic blood pressure(SBP), diastolic blood pressure(DBP), Oxygen saturation (SpO2), End Tidal Co2 (EtCO2) and postoperative nausea and vomiting(PONV)Timepoint: baseline,and every 2 hours for 24 hour. | — |
Countries
India
Contacts
Public ContactDr Shamrood Ahamed
Baby Memorial Hospital
Outcome results
None listed